Related references
Note: Only part of the references are listed.MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene
Shuai Jiang et al.
CANCER RESEARCH (2010)
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism
Paola Secchiero et al.
BLOOD (2009)
The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAs
Ariadne Androulidaki et al.
IMMUNITY (2009)
Foxp3-Dependent MicroRNA155 Confers Competitive Fitness to Regulatory T Cells by Targeting SOCS1 Protein
Li-Fan Lu et al.
IMMUNITY (2009)
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
Mojca Jongen-Lavrencic et al.
BLOOD (2008)
The MDM2 inhibitor nutlins as an innovative therapeutic tool for the treatment of haematological malignancies
Paola Secchiero et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
miRNA analysis in B-cell chronic lymphocytic leukaemia:: proliferation centres characterized by low miR-150 and high BIC/milk-155 expression
M. Wang et al.
JOURNAL OF PATHOLOGY (2008)
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia
Chris Saddler et al.
BLOOD (2008)
Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis
S. Marton et al.
LEUKEMIA (2008)
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells
Paola Secchiero et al.
CURRENT DRUG METABOLISM (2007)
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)
Paola Secchiero et al.
BLOOD (2006)
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes
D Campioni et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors
J Reddy et al.
ONCOGENE (2005)
SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma:: implications for epigenetic activation of the Jak/STAT pathway
CS Chim et al.
LEUKEMIA (2004)
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma
O Galm et al.
BLOOD (2003)
Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation
J Frantsve et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
